Merck Serono to lose Swiss HQ and 500 people
This article was originally published in Scrip
Merck KGaA will close the Geneva headquarters of its pharmaceutical business, Merck Serono, and cut 500 jobs, according to cost-saving plans announced today. "It just wasn't working financially to have two pharmaceutical headquarters and R&D hubs in Europe," a spokesperson told Scrip. "The whole point of the efficiency programme is to make the company more profitable and viable for the future."